A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
Public ClinicalTrials.gov record NCT01536041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled, Four-way Crossover Study to Compare the Safety and Efficacy of ONO-6950 20 mg and 200 mg QD Versus Placebo and Montelukast (Singulair) in Asthmatic Patients Who Experience Exercise-induced Bronchoconstriction
Study identification
- NCT ID
- NCT01536041
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ono Pharma USA Inc
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- ONO-6950 Drug
- Montelukast Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2012
- Primary completion
- Oct 31, 2012
- Completion
- Not listed
- Last update posted
- Feb 13, 2014
Started 2012
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles Clinical Site 110 | Los Angeles | California | 90025 | — |
| San Diego Clinical Site 140 | San Diego | California | 92123 | — |
| Denver Clinical Site 160 | Denver | Colorado | 80230 | — |
| North Dartmouth Clincial Site 150 | North Dartmouth | Massachusetts | 02747 | — |
| Minneapolis Clinical Site 190 | Minneapolis | Minnesota | 55402 | — |
| Princeton Clinical Site 170 | Princeton | New Jersey | 08558 | — |
| Raleigh Clinical Site 130 | Raleigh | North Carolina | 27607 | — |
| New Braunfeis Clinical Site 120 | New Braunfels | Texas | 78130 | — |
| San Antonio Clinical Site 180 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01536041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01536041 live on ClinicalTrials.gov.